Belong News
24 articles
/PRNewswire/ -- Belong.Life, a leading global provider of AI-powered patient education and support solutions, announced today that the European Society For...
Belong.Life, a global provider of AI-powered patient education and support solutions, announced that its AI cancer mentor, BelongAI Dave, received positive validation from a multi-institutional study. The study, presented at the European Society For Medical Oncology (ESMO) conference, involved nine senior oncologists who evaluated Daves ability to provide relevant and helpful cancer management support. The AI mentor achieved a 91.35% positive validation rate for its recommendations. The findings underscore the reliability and accuracy of Dave in supporting cancer patients and caregivers. Belong.Life continues to leverage AI, big data, and patient communities to enhance patient engagement and healthcare outcomes.
How this app helps those diagnosed with cancer
Veronica Conte, a hairdresser in the Poconos, used the Belong.Life App to navigate through her cancer journey. The app provides support and information to people with cancer and their families. Dr. Daniel Vorobiof, the medical director of the app, emphasizes the complexity of cancer and the importance of additional resources like the app. With an estimated 1.9 million new cancer cases predicted for 2022 in the US, the app serves as a supplement to traditional medical treatment. Veronica Conte urges people to listen to their bodies and consult a doctor if they notice anything unusual.
Customers
Belong.Life rolls out online community for patients with chronic myeloid leukemia
Belong.Life is launching an online community for individuals living with chronic myeloid leukemia, providing support groups, navigation tools, and access to professionals. The community aims to help patients get more engaged with their health and improve their treatment journeys. Belong.Life has raised $40 million in equity since its founding in 2015. The larger trend of providing online communities for patients with shared conditions is exemplified by the acquisition of PatientsLikeMe by UnitedHealth Group in 2019.
Customers
Belong.Life Creates Dedicated Chronic Myeloid Leukemia Community Within World's Largest Cancer App
Belong.Life has launched a dedicated community for chronic myeloid leukemia (CML) patients on its Belong-Beating Cancer Together app. The community will provide educational content customized to CML patients and caregivers, as well as a CML Tracker tool to monitor symptoms. Belong.Life aims to provide the largest engagement and education network for CML patients and caregivers in the United States. The company develops social and professional patient engagement networks for managing and navigating various diseases and patient communities. The launch of the CML community is expected to have a positive impact on the companys growth.
Customers
Belong.Life Launches i-Belong High-Engagement Platform, Allowing Providers, Health Plans, Advocacy Groups and Other Health Ecosystem Players to Easily Build Self-Managed Online Patient Communities
Belong.Life has launched i-Belong, a self-managed platform for health ecosystem players to build customizable communities and social networks. The platform offers personalized and configurable engagement tools for payers, providers, pharmaceuticals, and patient advocacy groups. Belong.Lifes existing customers and partners include groups working in cancer, multiple sclerosis, PTSD, psoriasis, autism, and other health indications. The launch of i-Belong is expected to have a positive impact on the companys growth. The article highlights the importance of digital patient communities and the challenges faced by third-party organizations in building and maintaining them. Belong.Lifes apps serve as global social networks and disease navigation platforms, providing personalized information and support to patients. The i-Belong platform has been praised by healthcare professionals for its ability to improve care coordination and personalized communication.
CustomersPartners
Belong.Life Expands its Comprehensive Multiple Sclerosis Networking and Navigation App to Support the French-Speaking Canadian Community
Belong.Life, the developer of social and professional networks for managing diseases, has announced the expansion of its BelongMS app to include a French language option for the French-speaking Canadian community. The app aims to connect multiple sclerosis (MS) patients, caregivers, and healthcare professionals to help navigate the condition and its treatment. Canada has one of the highest rates of MS in the world, and the expansion of the apps language options comes in response to numerous requests from French-speaking citizens. Belong.Lifes mission is to improve the quality of life and care through technology, engagement, data, and AI for patient communities, healthcare organizations, pharma, and hospitals.
Customers
https://multiplesclerosisnewstoday.com/sponsored-content/2021/03/04/belongms-regain-control-over-your-life-while-living-with-ms/
Belong.Life Releases Real-World Evidence Data of Financial Toxicity in Cancer Patients Receiving Immunotherapy
Belong.Life, a developer of social and professional networks for managing and navigating treatments, has published a study showing that almost half of cancer patients receiving immunotherapy and suffering from Financial Toxicity (FT) were not aware of the possible development of FT prior to treatment. The study highlights the importance of discussing the financial burden of cancer with patients early on in the treatment journey. The research will be presented at the ESMO Virtual Congress 2020. Belong.Life aims to provide a digital platform that unites medical professionals, patients, and organizations to advance the global cancer treatment standard.
Customers
Israeli CEO scores big-time recognition as top innovator in healthcare
Israeli startup Belong.Lifes CEO, Eliran Malki, has been recognized as one of Modern Healthcares Top 25 Innovators. Belong.Life develops social and professional networks for managing medical treatments, with a focus on cancer patients. The company has expanded to develop apps for MS patients, caregivers, and medical professionals, as well as a COVID-19 app. Belong.Lifes apps are free and anonymous, providing personalized experiences and access to relevant information. The company collaborates with research partners and has published studies based on data gathered from its community. The recognition highlights the importance of Israeli tech solutions and the minds behind them.
Customers
Trial platform matches cancer patients to clinical care
Belong.Life is a network that connects cancer patients with clinical research projects. The company uses technology, including AI and machine learning, to help patients find relevant clinical trials. Belong.Life offers various social networks and platforms for managing and navigating treatments and diseases. Their flagship app, Belong - Beating Cancer Together, is the worlds largest and fastest-growing digital cancer platform. They have also launched BelongMS, an app for multiple sclerosis (MS) patients. The challenges associated with clinical trial recruitment for MS patients include lack of awareness and limited time to discuss options with medical professionals. Belong.Life provides personalized content, a clinical trial matching service, and a social network for MS patients to connect with medical professionals.
Customers
Belong.Life Launches All-in-One Networking and Navigation App to Support Multiple Sclerosis Patients and Professionals
Belong.Life has launched a new free and anonymous AI-powered social networking and navigation platform for multiple sclerosis (MS) patients, caregivers, and healthcare professionals called BelongMS. The app provides hyper-personalized information, support groups, access to medical professionals, and useful tools for managing medical records. Belong.Life aims to support patients throughout their MS journey and uncover new insights into patient journeys. The app was initially launched in Israel and will now be available globally. Around 2.3 million people live with MS worldwide, and the app addresses the need for access to updated information about treatments. Belong.Life is known for developing social networks for managing and navigating treatments, including the worlds largest social network for cancer patients.
Customers
Now cancer patients can ask coronavirus questions to support app
Belong.Life, the world’s largest social networking app for cancer patients, has launched a free anonymous support group to help cancer patients during the COVID-19 pandemic. The group allows cancer patients to ask medical professionals questions about how the novel coronavirus could affect them as they battle cancer or navigate remission. The support group is overseen by Belong Chief Medical Director, oncologist Dr. Daniel Vorobiof. The questions asked in the group range from self-concern questions about treatment and susceptibility to catching the virus, to social-concern questions about managing illness around family and protecting cancer patients. The majority of questions are coming from the United States.
Customers
Belong.Life Broadens Global Impact - Onco'Zine
Belong.Life, the worlds largest social network for cancer patients, has partnered with The Breast Health Foundation and The Pink Parasol Project to provide support to breast cancer patients in South Africa. The partnership aims to improve the quality of life for breast cancer patients by increasing access to medical information, connecting individuals to support communities, and providing personalized tools. Belong.Lifes mobile app, Belong - Beating Cancer Together, offers customized information, clinical trial matching, emotional support forums, and access to medical experts. The company recently launched its Patient Engagement Platform (PEP) to extend services to a wider range of therapeutic areas. The partnership with BHF and The Pink Parasol Project is a growth-positive development for Belong.Life.
PartnersCustomers
Israeli app becomes world's largest cancer social network
Belong.life, an Israeli-made app for navigating the cancer journey, has become the worlds largest social network for cancer patients. The app uses artificial intelligence to provide personalized information and support to users based on the experiences of 200,000 cancer patients, caregivers, and health professionals. Belong also allows patients to ask questions to oncologists, who can use the apps AI to analyze patient data and develop new treatment protocols. The app is free for patients, while hospitals and other partners can white label the app for a fee. Belong is now expanding beyond cancer to address other medical conditions.
CustomersPartners
Technology and Society: The internet and its discontents Opinion - Internet Do
Cancer social network app Belong.Life raises $14 million Series B to accelerate and expand the rollout of its patient engagement and health research platform
Belong.Life, the world’s largest social network for cancer patients, caregivers, and healthcare professionals, has raised $14 million in Series B funding. The funding will be used to expand the platform and advance the Belong Patient Engagement Platform (PEP). Belong.Life was founded in 2015 and provides a free patient navigation app for cancer patients. The Belong global community has partnerships with leading patient advocacy associations and healthcare providers. The new Belong PEP aims to improve patient engagement, education, compliance, satisfaction, and auto-care coordination. The funding round was led by IQVIA, with participation from The Group Ventures and other existing investors.
InvestmentExpand
Belong.Life Launches End-to-end Patient Engagement Platform for Payers, Providers, Pharma and Advocacy Groups
Belong.life, the company behind the worlds largest interactive social network for cancer patients, caregivers and healthcare professionals, has announced the availability of its new Patient Engagement Platform (PEP). The platform is designed to improve patient engagement, education, compliance, satisfaction, auto-care coordination and efficiency. It provides patients, payers, providers, pharma and advocacy groups with hyper-personalized and configurable patient engagement tools, navigation and management services. The platform leverages Belongs machine learning and artificial intelligence expertise to provide superior engagement, user acquisition and data insights.
CustomersPartners
Helping Patients Navigate Cancer With The Power And Simplicity of Waze
The article discusses the Belong app, which provides personalized solutions for cancer patients and their families. It helps manage and fight cancer more effectively by providing access to healthcare professionals, organizing documents, and offering personalized information and notifications. The app also includes a clinical trial matching service. Belong has become the largest cancer network in the world with 150,000 active members and is available in 129 countries. The companys analytics have resulted in a hyper-personalized approach for users. The article highlights the shift from control to collaboration in medicine and the importance of patient engagement. The Belong app aims to make the cancer journey more navigable and empower patients to have a greater influence in future care and drug development.
CustomersPartnersInvestment
Belong.Life - Combating The Big C, With Help
The article discusses Belong.Life, an app that provides support and advice for cancer sufferers. The app connects users with an online community where they can seek advice from fellow sufferers and medical professionals. It also offers information about side effects, symptoms, and local clinical trials. Belong.Life aims to provide essential support for people going through a hard time. The impact on the company is growth-positive as it offers a valuable service to cancer patients and their families.
Customers
Belong.Life Surpasses 100,000 Cancer Patients and Caregivers, Solidifying Position as World's Largest Social Cancer Network
Belong.Life, a mobile app for cancer patients and caregivers, has reached over 100,000 active users. The app provides access to cancer information, physician communication, clinical trial matching programs, and social support. Belong.Life has the largest number of cancer patients compared to other patient-oriented platforms, making it an important resource for cancer information and networking. The app connects patients across the US, Europe, and beyond, providing an accessible and anonymous community for people to understand their diagnoses and navigate treatment. Belong.Life also uses big data and machine learning technology to offer personalized alerts and support programs for healthcare providers. The company collaborates with leading universities, cancer advocacy groups, and organizations. Belong.Life is the worlds largest digital cancer patient platform and is in partnership with the American Cancer Society, Colorectal Cancer Canada, Janssen Pharmaceuticals, and others.
Customers
Finn Partners Teams Up with Belong.Life, World's Largest Cancer-Focused Social Platform, to Improve Patient Care Through Communications
Belong.Life, the worlds largest cancer-focused social platform, has released a real-world data survey to evaluate the impact of fatigue on cancer patients treatment. The survey, completed by over 500 patients, revealed correlations not evident to other analyses. Belong.Life is partnering with Finn Partners, a healthcare agency, to expand its reach to patients, providers, and advocacy groups. The survey also highlighted the importance of communication in the treatment journey, with emotional and physical indicators being seen as markers of therapy success or failure. Belong.Life is committed to giving a voice to cancer patients and their support networks and aims to expand awareness about medical product innovations and provide support to patients. Belong.Life will present a patient-reported outcomes study at the 2018 American Society of Clinical Oncology Annual Meeting.
Customers
Belong.Life and American Cancer Society to Mobilize Cancer Patients Online With Social Network
Belong.life, the worlds largest cancer patient and caregiver social network, has announced that its new closed-member forum has generated over one million views and 4,000 chat discussions with the American Cancer Society (ACS) care team in the first six months post-launch. The collaboration with ACS allows Belongers to access cancer research news, important ACS updates, patient-tailored online resources, and network with others facing similar cancer-related issues. Belong.life estimates that the ACS forum will generate over 8 million views in the next 12 months. The platform aims to provide cancer patients with authoritative information and a supportive community as they navigate their diagnoses, treatment, and life journey.
Customers
Belong partners with American Cancer Society to help beat cancer with AI
Belong: Beating Cancer Together has announced a partnership with the American Cancer Society to provide patients with personalized information, education, and assistance. The partnership adds a closed forum for American Cancer Society members, allowing them access to its online patient-doctor community. Belong uses AI and machine learning to develop a powerful real-world patient-generated data lake and to better understand patient profiles and journeys. The partnership with the American Cancer Society adds their information, insights, and resources to the Belong network. Belongs mission is to analyze the data generated and use it to advance science and cancer research.
Partners
Belong app aims to help patients navigate cancer's twists and turns
The article discusses the mobile app called Belong, which allows cancer patients to exchange experiences, information, and tips, as well as access medical professionals and experts. The app aims to fill the gap of missing critical information and provide support and guidance to cancer patients. Belong has partnered with hospitals in Israel and Canada and plans to expand to the US. The app already has a few thousand users and offers features such as treatment task journal, user groups, and a digital medical binder. The company has raised $1.5 million from angel investors and plans to start a Series A funding round.
CustomersPartners
